
    
      Materials and Methods: This is a perspectiveness ,randomized, opening study, patients will be
      randomly assigned to the standarddose Saxagliptin group ,the lifestyle intervention group,the
      Metformin group and the low dose Saxagliptin group with a 6-month treatment period.

      Oral glucose tolerance test will examined before and 6 months post-treatment during the
      trial.
    
  